The researcher assessed data from 184 countries to estimate global cases of Type 2 diabetes and cardiovascular disease due to ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...

Nearly half of Type 2 diabetes patients suffer from micronutrient deficiencies, with vitamin D and magnesium being the most ...

With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick.

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

Micronutrient deficiency, whereby levels of vitamins and minerals essential for healthy bodily function are far too low, is ...

Micronutrient deficiencies, such as low vitamin D and magnesium, are alarmingly common in people with type 2 diabetes, ...

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according t ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...